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Phosphdinositide-specific phospholipase C (PLC) activity of human platelet membranes was activated by the nonhydro- 
lyzable guanine nucleotide GTPyS. This activation did not occur in either membranes prepared from dibutyryl cyclic 
AMP-pretreated platelets (A-membranes) or those prepared from untreated cells and subsequently incubated with cyclic 
AMP (CAMP) (B-membranes). This CAMP-mediated inhibition was abolished in the presence of inhibitors of CAMP- 
dependent protein kinase (A-kinase), suggesting that the inhibition was due to phosphorylation of (a) protein compo- 
nent(s). No significant differences were observed in the basal PLC activity and the extent of pertussis toxin-catalyzed 
ADP-ribosylation among control membranes and the two types of phosphorylated membranes (A- and B-membranes). 
GTP-binding activities of G,, Gi and GTP-binding proteins of lower molecular masses were not altered by the phosphory- 
lation of the membranes. These tindings suggest that a GTP-binding protein is involved in the GTPyS-mediated activation 
of PLC and that CAMP (plus A-kinase) inhibits this activation by phosphorylating amembrane protein (probably a 240- 
kDa protein), rather than the GTP-binding protein or PLC itself. It is likely that this phosphorylation uncouples the 
GTP-binding protein from PLC. 
Phosphoinositide-specific phospholipase C; GTP-binding protein; cyclic AMP-dependent protein kinase; (Human platelet) 
1. INTRODUCTION 
Like many cells, platelets possess both positive 
and negative control systems for transduction of 
extracellular signals. Activation of platelets by ex- 
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4,5-bisphosphate; Gpp(NH)p, guanosine 5’-v,y-imidohri- 
phosphate; App(NH)p, adenosine 5 ’ -@,y-imido)triphosphate; 
8-N3-GTP, I-azido-guanosine 5 ‘-triphosphate; H-8, N-[2-(me- 
thylamino)ethyl]-5-isoquinoline sulfonamide dihydrochloride; 
G-protein, GTP-binding protein; G, and Gi, the stimulatory 
and inhibitory G-proteins, respectively, of adenylate cyclase; 
A-kinase, CAMP-dependent protein kinase; A-membranes, 
membranes isolated from dbcAMP-pretreated platelets; 
B-membranes, membranes prepared from untreated platelets 
and then incubated with CAMP in the presence of Mg’+ and 
ATP 
citatory stimuli is accompanied by an increase in 
intracellular Ca2+ that initiates cellular responses 
[ 11. Inhibitory stimuli, on the other hand, provoke 
an increase in CAMP that inhibits the Ca’+-in- 
duced responses. It has been reported that the 
increase in CAMP prevents the agonist-induced 
activation of phosphoinositide-specific phospholi- 
pase C [2,3]. This inhibition has been thought to be 
mediated by A-kinase, but its mechanism is only 
poorly understood. 
Accumulating evidence indicates that PLC ac- 
tivity of platelets is regulated by a G-protein [4,5]. 
The addition of GTP or its non-hydrolyzable 
analogue GTPyS to permeabilized platelets or 
membranes prepared therefrom has been shown to 
enhance the formation of inositol 1,4,5trisphos- 
phate and diacylglycerol [6]. It has also been 
reported that treatment of permeabilized platelets 
with pertussis toxin leads to the abolition of the 
ability of thrombin to activate cellular responses 
including phosphoinositide hydrolysis [7]. This ef- 
368 
Published by Eisevier Science Publishers B. V. (Biomedical Division) 
00145793/89/$3.50 0 1989 Federation of European Biochemical Societies 
Volume 242, number 2 FEBSLETTERS January 1989 
feet of the toxin is most likely due to the ADP- 
ribosylation of a 40-41-kDa G-protein subunit in 
platelet membranes [8,9]. As for the inhibitory 
action of CAMP on PLC activation in stimulated 
platelets, it has been suggested that CAMP 
(together with endogenous A-kinase) phosphory- 
lates a receptor and reduces the ability of platelets 
to bind and respond to thrombin [lo]. However, 
since the GTPyS-induced IP3 formation is in- 
hibited in CAMP-treated platelet membranes, it is 
likely that (a) certain post-receptor step(s) is (are) 
affected by CAMP. The present study was under- 
taken to shed light on the mechanism underlying 
the CAMP-mediated suppression of GTPyS- 
induced activation of PLC. 
2. MATERIALS AND METHODS 
2.1. Preparation of platelet membranes 
Human platelet membranes were prepared by the method of 
Katada et al. [l l] with slight modifications. A platelet suspen- 
sion was incubated at 37°C for 5 min in the presence and 
absence of 1 mM dbcAMP. The platelets were then washed 
twice with ice-cold Tyrode-Hepes buffer, pH 6.8, containing 
10 mM EDTA and resuspended in 20 mM Tris-HCl buffer, pH 
6.8, containing 5 mM EDTA. The washed platelets were 
homogenized in a teflon-glass homogenizer (40 strokes) and the 
resulting homogenate was centrifuged twice at 20000 x g for 
25 min at 4°C. The final pellet was suspended in 2-3 vols of 
Hepes buffer, pH 6.8, containing 1 mM EDTA and 0.1 mM 
DTT to a protein concentration of 8-11 mg/ml and frozen at 
- 80°C until use. The membrane preparations obtained from 
untreated and dbcAMP-pretreated platelets were termed con- 
trol membranes and A-membranes, respectively. B-membranes 
were obtained by incubating the control membranes with 1 PM 
CAMP, 20 PM ATP and 5 mM Mg’+ at 37°C for 5 min, follow- 
ed by washing with and resuspending in the same buffer. 
2.2. Assay of PLC activity 
PLC activity was assayed, by measuring the formation of 
[‘H]IPs from [3H]phosphatidylinositol 4,5_bisphosphate 
([‘H]PIPz) as described in [12]. The standard reaction mixture 
(final volume, 68 ~1) contained 25 mM Tris-maleate buffer, pH 
5.5, 50 mM KCI, 2 mM EGTA, 2 mM CaClz, 1 mM MgClz, 
100/M [‘HIPIP% (15000 cpm) and membranes (1-20/g pro- 
tein). For PLC assay of phosphorylated membranes, control 
membranes were preincubated in the phosphorylation mixture 
described below except that [y-3ZP]ATP was replaced by 
unlabelled ATP and the mixture was cooled rapidly at 4°C for 
2 min. An aliquot of the phosphorylated membrane suspension 
was added to the standard assay mixture for PLC activity. Pro- 
tein was determined using a Bio-Rad protein assay kit with 
bovine serum albumin as a standard. 
2.3. Phosphorylation of platelet membranes 
The reaction mixture (final volume, 200 ~1) contained 25 mM 
Tris-HCl buffer, pH 7.5, 5 mM MgC12 and 20pM [y-32P]ATP. 
Where indicated, 1 CM CAMP, 10 fig of A-kinase purified from 
bovine heart, 10pM H-8 or 1Org protein kinase inhibitor 
(Type-II) was added. The reaction was run at 30°C for 2-5 min 
and stopped by heating the mixture at 100°C for 2 min after the 
addition of 0.5 vol. of SDS-stop solution 1150 mM Tris-HCI 
buffer, pH 6.8, containing 7.5% SDS, 12% glycerol, 4.5% 
2-mercaptoethanol (w/v)]. The phosphorylated proteins were 
analyzed by SDS-polyacrylamide gel electrophoresis (SDS- 
PAGE) [13]. The gels were then subjected to autoradiography 
at - 80°C for 24-48 h using X-Omat K films. 
2.4. ADP-ribosylation of platelet membranes 
Pertussis toxin-catalyzed ADP-ribosylation of membrane 
proteins was measured essentially as described previously [ 141. 
The reaction mixture (final volume, 100 ~1) contained 20 mM 
Tris-HCI buffer, pH 8.0, 1 mM EDTA, 1 mM DTT, 1 mM 
ATP, 3 mM potassium phosphoenolpyruvate, 10 mM 
thymidine, 10 pg/ml pyruvate kinase, l-2.5 pM [(r-“PINAD 
(1000 Ci/mmol), 5 pg/ml of pertussis toxin preincubated with 
10 mM DTT and 1 mM ATP at 30°C for 15 min, and mem- 
branes (10-40 fig protein). Incubation was conducted at 30°C 
for indicated periods of time, and the reaction was terminated 
by heating the mixture at 100°C for 2 min after the addition of 
50 ~1 of the SDS-stop solution. The mixture was then subjected 
to SDS-PAGE and ADP-ribosylated proteins were visualized by 
autoradiography at -80°C for 24-48 h. 
2.5. Photoaffinity labelling with 8-azido-[y-32PJguanosine 
5 ‘-triphosphate 
The standard reaction mixture (final volume, 100 cl) contain- 
ed 20 mM Mops buffer, pH 7.5, 1 mM EDTA, 100 mM NaCl, 
25 mM MgC12, 1 mM App(NH)p, 1 PM 8-Nr-[r-“P]GTP and 
membranes (20rg) in the presence and absence of 1 mM 
unlabelled GTP or 1 mM GDP [15]. The mixture was incubated 
in the dark for 10 min at 4°C and then irradiated for 10 min 
with a UV lamp (wavelength, 254 nm) from a distance of 1 cm. 
The mixture was then kept at 100°C for 2 min after the addition 
of 50~1 of the SDS-stop solution. The labelled proteins were 
analyzed by SDS-PAGE and visualized by autoradiography. 
2.6. Chemicals and biochemicals 
[‘H]PIPz, [y-32P]ATP and [LU-~*P]NAD were purchased from 
New England Nuclear, 8-Nr-[y-‘*P]GTP from ICN, pertussis 
toxin and H-8 from Seikagaku Kogyo, dbcAMP, GTP, ATP, 
purified bovine heart A-kinase and protein kinase inhibitor 
(Type-II) from Sigma, and App(NH)p, Gpp(NH)p, guanosine 
5 ’ -(2-O-thio)diphosphate (GDP,&) and GTPyS from Boehr- 
inger, Mannheim. All other chemicals were of reagent grade. 
3. RESULTS AND DISCUSSION 
The effects of several nucleotides on PLC activi- 
ty of human platelet membranes are shown in 
fig.1. Among the nucleotides tested, the 
nonhydrolyzable guanine nucleotides GTPyS and 
Gpp(NH)p were the most potent activators of the 
enzyme. GTP was also effective, though to a lesser 
extent. GDP@ repressed the stimulatory effects of 
GTPyS and Gpp(NH)p. These findings indicate 
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Fig. 1. Effects of nucleotides on PLC activity. PLC assays were 
performed as described in section 2 using 15 pg of platelet 
membrane protein/assay and 10 min incubation time at 37°C. 
Results were expressed as percentage of maximal activation 
obtained by the addition of 100/M GTPrS. The figure is 
representative of three different experiments that gave similar 
results. 
that a G-protein is involved in this activation, in 
agreement with previous reports [12,16,17]. Rock 
et al. [18] have, however, reported that G-protein 
is not responsible for the activation of PLC in 
human platelets. The reason for this discrepancy is 
unclear. 
PLC activity of control membranes prepared 
from untreated platelets was stimulated by GTPyS 
in a dose-dependent manner, whereas GTPyS did 
not enhance the enzyme activity in A-membranes 
prepared from dbcAMP-pretreated cells (not 
shown). Nevertheless, there were no significant 
differences between the basal PLC activities of 
control and A-membranes. B-membranes, 
prepared from untreated platelets and then in- 
cubated with CAMP in the presence of Mg2+ and 
ATP, also showed the same basal PLC activity, 
which was activated by GTPyS only slightly 
(fig.2). In the presence of H-8, an inhibitor of A- 
kinase, however, GTPyS stimulated the PLC ac- 
tivity even in the CAMP-treated membranes (B- 
membranes) (fig.2). As shown in fig.3, the addi- 
tion of CAMP alone or CAMP plus purified A- 
kinase together with ATP and Mg2+ to platelet 
membranes caused the phosphorylation of 22-, 
24-, 50- and 240-kDa proteins (lanes A and C), 
which have been shown to serve as substrates for 
A-kinase [ 191. This phosphorylation was inhibited 
Fig.2. Effects of CAMP and H-8 plus CAMP on GTP+- 
stimulated PLC activity. Membranes (200 fig) from untreated 
cells were preincubated with following reagent(s): 
UNTREATED, 5 mM MgCl2; CAMP-TREATED, 5 mM 
MgCls, 20pM ATP and 1 FM CAMP; CAMP + H-8, 5 mM 
MgCl2, 20pM ATP, 1 CM CAMP and 1OpM H-8. After 
incubation for 5 min at 3O”C, ice-cold Tyrode-Hepes buffer, 
pH 6.8, containing 1 mM EDTA and 0.1 mM DTT was added 
to samples. The mixtures were washed twice by centrifugation 
at 20000 x g for 20 min at 4°C and the final pellet was 
resuspended in 2OOfil of the same Tyrode-Hepes buffer 
containing EDTA and DTT. 20 pl of the mixtures was used for 
assay of PLC activity. PLC activity was measured in the 
presence or absence of 100 PM GTPrS as described in section 
2. Results were expressed as means f SE from three separate 
experiments. 
by H-8 (lanes B and D). Protein kinase inhibitor 
(Type-II), another A-kinase inhibitor, behaved 
similarly towards the GTPyS-induced PLC activa- 
tion and the protein phosphorylation (not shown). 
It is thus evident that protein phosphorylation by 
A-kinase is responsible for the inhibition of PLC 
activation. However, since the basal PLC activities 
of both A- and B-membranes were practically the 
same as that of control membranes, it is unlikely 
that A-kinase phosphorylated PLC directly. In 
fact, PLC purified from human platelet mem- 
branes [20] was not phosphorylated by A-kinase 
(unpublished). It can be assumed that A-kinase 
phosphorylates either the G-protein involved or a 
component functional between the G-protein and 
PLC and thus uncouples the G-protein from PLC. 
ADP-ribosylation of a-subunits of G-proteins 
by cholera toxin (for G,) and pertussis toxin (for Gi 
and G,) has been widely used to assess the func- 
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Fig.3. Autoradiograph of SDS-PAGE showing phosphoryla- 
tion of platelet membrane proteins by A-kinase. Membranes 
were isolated from untreated platelets. Phosphorylation of the 
membranes was performed as described in section 2 in the 
presence of following addition(s): lane A, exogenous A-kinase 
and CAMP; lane B, exogenous A-kinase, CAMP and H-8; lane 
C, CAMP; lane D, CAMP and H-8; lane E, none; lane F, H-8. 
Proteins were separated by SDS-PAGE and phosphorylated 
proteins were detected by autoradiography. The autoradio- 
graphic patterns of 12% SDS-PAGE, representative of three 
separate xperiments, are shown. 
tions of G-proteins. Pertussis toxin has been found 
to block the PLC activation in such cells as 
neutrophils [21,22] but not in others [23,24]. In the 
case of platelets, this toxin has been reported to 
both enhance [25] and inhibit [7] the thrombin- 
mediated activation of PLC. At any rate, the pre- 
sent study showed that CAMP treatment of human 
platelet membrane did not affect the pertussis 
toxin-catalyzed ADP-ribosylation of a 40-kDa (a-) 
subunit of a G-protein (not shown). Furthermore, 
it was found that the addition of GTPyS and Mg2+ 
decreased the ADP-ribosylation of the 40-kDa 
protein to the same extent in control, A- and B- 
membranes (not shown). Quantitative analysis by 
the rapid filtration method (using nitrocellulose 
filters) could confirm that the extents of ADP- 
ribosylation in control, A- and B-membranes were 
practically the same with one another (not shown). 
These results appear to exclude the possibility that 
CAMP directly affects the G-protein, which is ef- 
fectively ADP-ribosylated by pertussis toxin. 
Recent studies have demonstrated the occur- 
rence in platelet membranes of another family of 
G-proteins, which have smaller molecular masses 
(21-29.5kDa) and are insensitive to the action of 
pertussis toxin [26,27]. Although the G-protein in- 
volved in the PLC activation has not yet been iden- 
tified in platelets, the possibility exists that the 
activation of the G-protein is accompanied by an 
exchange of GDP by GTP, as in the case of the 
adenylate cyclase system. If this is the case, then it 
is likely that the CAMP-induced suppression of 
PLC activation is caused by the CAMP-dependent 
phosphorylation of the G-protein, leading to the 
inhibition of this GDP-GTP exchange. It was, 
therefore, expected that the GTP-binding activity 
of the G-protein would be attenuated by pretreat- 
ment of control membranes with dbcAMP. To test 
this possibility, photoaffinity labelling of control 
and A-membranes was conducted with 
8-N&-32P]GTP as a label. Both types of mem- 
branes were incubated with 8-N3-[y-32P]GTP in 
the dark and then photolyzed. App(NH)p was in- 
cluded in the incubation mixture to prevent 
nonspecific nucleotide binding. As shown in fig.4, 
Fig.4. Photoaffinity labelling by 8-Ns-[y-‘*P]GTP. Membranes 
were isolated from untreated control and dbcAMP-pretreated 
cells, and photoaffinity labelling was performed as described in 
section 2. Samples are as follows: lane A, membranes incubated 
with 8-Ns-[y-‘*P]GTP in the dark; lane B, membranes 
incubated with 8-Ns-[y-32P]GTP and unlabelled 1 mM GTP in 
the dark and irradiated with UV; lane C, membranes incubated 
with 8-2%~[y-“P]GTP in the dark and irradiated with UV; lane 
D, dbcAMP-pretreated membranes incubated with 
8-N3-[y-32P]GTP in the dark and irradiated with UV. Lane C’ 
and lane D’ (the same samples of lane C and lane D) were 
excessively exposed for 5 days. The autoradiographic patterns 
of 9% SDS-PAGE, representative of three separate 
experiments, are shown. 
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we could thus detect the labelling of G,, Gi (lanes 
C and C’) and smaller G-proteins of 21-27-kDa 
(not shown) in control membranes. This labelling 
was blocked by either GTP (lane B) or GDP (not 
shown). In A-membranes G,, Gi and smaller G- 
proteins were labelled to the same extents as in 
control membranes (lanes D and D’). It was, 
however, found that a 240-kDa protein was much 
more strongly labelled in A-membranes than in 
control membranes. Since a protein having the 
same electrophoretic mobility as the 240-kDa pro- 
tein was phosphorylated by A-kinase (cf. fig.3), it 
may be concluded that the GTP-binding activity of 
this protein is enhanced by the A-kinase-catalyzed 
phosphorylation. 
Taken together, the results described above sug- 
gest that the CAMP-dependent phosphorylation of 
the 240-kDa membrane protein is responsible for 
the suppression of the GTPyS-induced activation 
of PLC. The phosphorylation seems to increase 
the capacity of the 240-kDa protein to bind GTP. 
It is likely that the binding of GTP to this protein 
somehow uncouples the functional connection be- 
tween the G-protein involved and PLC. 
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